JSW Steel vs Acutaas Chemicals: Ek taraf Capex ka Zor, Doosri taraf High P/E Ka Dhamaka!

CHEMICALS
Whalesbook Logo
AuthorIshaan Verma|Published at:
JSW Steel vs Acutaas Chemicals: Ek taraf Capex ka Zor, Doosri taraf High P/E Ka Dhamaka!
Overview

Aaj market mein do industries ki kahaani sunate hain. JSW Steel ne Q3 mein revenue toh badhaya hai aur profit bhi achha aaya hai, lekin margins thode tight hue hain. Wahi, Acutaas Chemicals ka profit **140%** se upar bhaga hai, par uska valuation bahut hi zyada lag raha hai!

JSW Steel: Growth toh hai, par Margins pe pressure!

JSW Steel ke liye Q3 FY26 ka result aaya hai aur numbers kaafi solid dikh rahe hain. Company ka consolidated profit after tax ₹2,410 crore raha, jo pichhle saal ke comparison mein kaafi acha jump hai. Iska reason hai zyada sales volumes aur BPSL se related deferred tax assets ka credit. Overall revenue bhi 11.2% badhkar ₹45,991 crore ho gaya. Lekin yahan ek twist hai, bhai! Adjusted EBITDA mein sequential dip aaya hai 16% ka, q ki realisations kam hui hain, aur operating margins bhi kam ho kar 14.37% ho gaye, jo pichhle quarter mein 15.97% the. India steel volumes 13.5% badh kar 7.4 million tonnes pahunch gaye, jo expectations se thoda upar hai.

Bade Plans, Bade Kharche

JSW Steel ab bada expansion karne ke mood mein hai. Odisha ke Jagatsinghpur mein ₹31,600 crore ka naya plant lagane wale hain, jisse 5 mtpa capacity aur jud jayegi. FY2030 tak total capacity 47 mtpa tak pahunchane ka target hai! Is bade kharche ko manage karne ke liye, company BPSL stake ko JFE JV ke through monetize kar rahi hai, jisse FY27 ke H1 tak ₹3,700 crore debt kam hone ki ummeed hai. Analysts ka consensus 'Moderate Buy' hai, jinka average 12-month target price ₹1,255 hai. Par bhai, badhti hui coal costs bhi margins ko thoda daba sakti hain.

Acutaas Chemicals: Profit ka Toofan, Par Valuation Pe Sawaal?

Acutaas Chemicals ne toh Q3 FY26 mein dhamaka kar diya! Net profit 140.18% badh kar ₹107.96 crore ho gaya, aur revenue bhi 42.98% badhkar ₹393.18 crore pahunch gaya. Operating margins toh record 38.32% par hain, mostly CDMO (Contract Development and Manufacturing Organization) business ki wajah se, jo ab FY25 revenue ka 85% ho gaya hai. Is CDMO focus se company clients ke supply chain mein aur zyada integrate ho rahi hai. Poore saal ke liye revenue growth guidance bhi badha kar 30% kar di hai.

Valuation Ka Mamla Aur Naye Segments

Par yahan ek bada sawaal uth raha hai – valuation. Acutaas Chemicals ka P/E ratio TTM basis par 55.72x se 68.16x ke beech mein hai, jo Indian Pharma industry ke average 28.2x aur baaki specialty chemical peers jaise Fineotex Chemical (28.8x) ya Vinati Organics (38.1x) se kaafi zyada hai. Baki ka revenue semiconductor aur battery ke liye specialty chemicals se aata hai, jo future growth ke liye ache hain, lekin abhi speculative hain aur inme invest karna padega. Analysts ka 'Buy' rating ke saath average price target ₹2,084.88 hai, matlab current levels se sirf 4.10% ka upside. Company ke high valuation aur naye segments ke risks ko dekhte hue, sabko dhyan se dekhna padega.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.